Recruiting

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Myotonic Dystrophy
+6

+ Facioscapulohumeral Muscular Dystrophy
+ Muscular Dystrophy
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: September 2000

Summary

Principal SponsorUniversity of Rochester
Study ContactRegistry Coordinator
Last updated: October 15, 2025
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 2000Actual date on which the first participant was enrolled.

Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry is to connect people with DM or FSHD with researchers studying these diseases. The registry will offer individuals with DM and FSHD an opportunity to participate in research that focuses of their diseases. The registry will also help scientists to accomplish research on DM and FSHD and to distribute their findings to patients and care providers. The National Registry of DM and FSHD Patients and Family Members was developed to create a link between patients and scientists in order to promote research on these rare illnesses. The Registry is sponsored by the National Institutes of Health. Patients that are interested in joining the Registry can email or call to request an application or download the forms from the website (www.dystrophyregistry.org). The Application packet contains: * A Patient Information Form, which asks about your muscle strength, general health, and how your disease affects your daily life * A Medical Records Release Form, which allows us to contact your doctor and obtain records about your diagnosis * An informed Consent Form, which describes the study's purpose and what you can expect while you are involved with the project. After you are enrolled in the Registry, there are several ways to participate in research. The activities include: * Complete an annual update form to help us keep track of how your symptoms change over time. * Receive updates about the progress of the Registry, research highlights, and other news related to muscular dystrophy through newsletters, an email listserv, and Facebook. * Receive letters from the Registry when researchers are looking for patients to take part in studies. These projects may include filling out questionnaires, exploring new treatments, and other types of research. There is no obligation to participate in these activities. Taking part in any study or filling out the annual updates are completely up to you.

Official TitleNational Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members 
Principal SponsorUniversity of Rochester
Study ContactRegistry Coordinator
Last updated: October 15, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
3000 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Other
Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

How participants are selected
Participants are selected without using randomization. They may be chosen based on convenience, access, or willingness to participate. This approach is common when random selection isn’t practical.
Another way to select participants is through a probability sample, where participants are chosen randomly, so everyone has an equal chance to be included.

How information is collected
Researchers start collecting data from the present day forward, following participants over time to observe outcomes. This approach helps identify how exposures or behaviors may lead to health events in the future.Other Ways to Collect Data
Retrospective
: These studies use existing medical records or past data.

Cross-sectional
: These studies collect data at one single point in time.

Others
: Some studies use a mix of approaches or less common designs depending on the research goal.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Healthy volunteers allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Myotonic Dystrophy
Facioscapulohumeral Muscular Dystrophy
Muscular Dystrophy
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Congenital Myotonic Dystrophy
PROMM (Proximal Myotonic Myopathy)
Steinert's Disease
Myotonic Muscular Dystrophy
Criteria

Inclusion Criteria: * Diagnosed with DM, FSHD, or related diseases or are an unaffected family member of someone diagnosed with one of these diseases


Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives


Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Recruiting
University of Rochester Medical Center, Department of NeurologyRochester, United StatesSee the location

Recruiting
One Study Center